Positive Results Revealed in Clinical Trial COMPARE 60/80 for High Bleeding Risk Patients
Pti: Positive Results Revealed in Clinical Trial COMPARE 60/80 for High Bleeding Risk Patients
Stay updated with breaking news from Clinical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pti: Positive Results Revealed in Clinical Trial COMPARE 60/80 for High Bleeding Risk Patients
KAIMRC, Sanofi agree to advance clinical research and build sustainable, AI-driven rare disease management ecosystem
Pti: Kasturba Medical College, Manipal's Clinical Embryology Centre Recognized as a 'Centre of Excellence' by Merck Foundation, Germany
Dapagliflozin became the first SGLT2 inhibitor approved for CKD alone just over 2 years ago, but uptake has lagged. Could a similar label gain for empagliflozin, plus a new recommendation, spark change?
Around 15 vaccine candidates are being developed in the battle against tuberculosis to compensate for the poor efficacy of the Bacillus Calmette-Guérin vaccine.